Advanced search×

Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.

Charles C Hsu, Joseph M Herman, Michele M Corsini, Jordan M Winter, Matthew D Callister, Michael G Haddock, John L Cameron, Timothy M Pawlik, Richard D Schulick, Christopher L Wolfgang, Daniel A Laheru, Michael B Farnell, Michael J Swartz, Leonard L Gunderson, and Robert C Miller

Ann Surg Oncol 17(4):981-90 (2010) PMID 20087786

Survival for pancreatic ductal adenocarcinoma is low, the role of adjuvant therapy remains controversial, and recent data suggest adjuvant chemoradiation (CRT) may decrease survival compared with surgery alone. Our goal was to examine efficacy of adjuvant CRT in resected pancreatic adenocarcinoma compared with surgery alone.

DOI: 10.1245/s10434-009-0743-7
Version: za2963e q8za3 q8zb5 q8zc9 q8zd1 q8ze9 q8zfc q8zgd
View PDF

Similar articles you may find interesting…

  1. Chemoradiation with Paclitaxel and Carboplatin in high-risk cervical cancer patients after radical hysterectomy: a korean gynecologic oncolo...
    Taek Sang Lee, Soon Beom Kang, and Kyung Tai Kim

    Int J Radiat Oncol Biol Phys 86(2):304-10 (2013) PMID 23642625

    To evaluate the efficacy and toxicity of concurrent chemoradiation with paclitaxel and carboplatin in patients with high-risk cervical cancer. Patients after radical hysterectomy for cervical cancer, with at least 1 high-risk characteristic, were administered paclitax...
    Buy PDF
  2. Differentially expressed epigenome modifiers, including Aurora kinase A and B, in immune cells of rheumatoid arthritis.
    Tibor T Glant, Timea Besenyei, and Tibor A Rauch

    Arthritis Rheum (2013) PMID 23653330

    Arthritis development is accompanied the changes in the expression of a number of epigenome-modifying enzymes. Drug-induced downregulation of the Aurora kinases, among other targets, seems to be sufficient to treat experimental arthritis. Development of new therapeutics that target the Aurora kinase...
    Buy PDF
  3. No effect of antifungal compounds on functional properties of human antifungal T-helper type 1 cells.
    L Tramsen, S Schmidt, and T Lehrnbecher

    Transpl Infect Dis (2013) PMID 23647945

    We therefore analyzed the effects of various concentrations of commonly used antifungal compounds such as amphotericin B, caspofungin, fluconazole, voriconazole, and posaconazole on the functional properties of cultivated human antifungal TH 1 cells. None of the antifungal compounds tested significa...
    Buy PDF